Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00660712
NCT00660712
Completed
N/A

Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey

AstraZeneca1 site in 1 country1,018 target enrollmentMarch 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBipolar Disorder

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bipolar Disorder
Sponsor
AstraZeneca
Enrollment
1018
Locations
1
Primary Endpoint
Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
Status
Completed
Last Updated
16 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Registry
clinicaltrials.gov
Start Date
March 2008
End Date
March 2009
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients previously or currently diagnosed with bipolar disorder
  • •Patients (or any of their relatives) who give a written informed consent.

Exclusion Criteria

  • •Patients who were previously included in this study.

Outcomes

Primary Outcomes

Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Secondary Outcomes

  • Identification of treatment modalities selected according to the disease phase
  • Identification of the number of first degree relatives diagnosed with bipolar disorder
  • Evaluation of the relationship between patient and disease characteristics
  • Evaluation of co-morbid psychiatric diseases
  • Evaluation of the time period that elapsed since the diagnosis of bipolar disorder

Study Sites (1)

Loading locations...

Similar Trials

Unknown
N/A
Clinical Pulmonary EmbolismAcute Pulmonary Embolism
NCT05469724Assiut University100
Recruiting
N/A
Venetoclax RegistryAcute Myeloid Leukemia
NCT03662724Hannover Medical School100
Withdrawn
N/A
Characteristics of Patients With COVID-19 in Meta State, ColombiaCOVIDSARS-CoV 2SARS PneumoniaSARS (Disease)SARS (Severe Acute Respiratory Syndrome)
NCT04456426Hospital Departamental de Villavicencio
Completed
N/A
Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination TherapyBreast Cancer
NCT04394247Pfizer242
Completed
N/A
A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on PanobinostatMultiple Myeloma
NCT04150289pharmaand GmbH248